• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RESITRA队列中肺移植后的肺炎:一项多中心前瞻性研究。

Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study.

作者信息

Aguilar-Guisado M, Givaldá J, Ussetti P, Ramos A, Morales P, Blanes M, Bou G, de la Torre-Cisneros J, Román A, Borro J M, Lama R, Cisneros J M

机构信息

Hospital Virgen del Rocío, Sevilla, Spain.

出版信息

Am J Transplant. 2007 Aug;7(8):1989-96. doi: 10.1111/j.1600-6143.2007.01882.x.

DOI:10.1111/j.1600-6143.2007.01882.x
PMID:17617864
Abstract

The aim of the present study is to evaluate the epidemiology, etiology and prognosis of pneumonia in lung transplant (LT) recipients. This is a prospective, multicenter study of a consecutive cohort of LT recipients in Spain. From September 2003 to November 2005, 85 episodes of pneumonia in 236 LT recipients were included (incidence 72 episodes per 100 LT/year). Bacterial pneumonia (82.7%) was more frequent than fungal (14%) and viral pneumonia (10.4%). The most frequent microorganisms in each etiological group were Pseudomonas aeruginosa (n = 14, 24.6%), CMV (n = 6, 10.4%) and Aspergillus spp. (n = 5, 8.8%). Incidence of Aspergillus spp. and CMV pneumonia is lower than previously reported, probably due to the spread of universal prophylaxis. Pneumonia caused by viruses appeared significantly later than pneumonia due to gram-negative bacilli, fungi and those without known etiology (p < 0.01, p = 0.03 and p = 0.02, respectively). The routine use of ganciclovir has changed the natural history of CMV infection, so that pneumonia appears later, once prophylaxis is suspended. The probability of survival during the first year of follow-up was significantly higher in the multivariate analysis in LT recipients who did not have a pneumonia episode compared with those that had at least one episode (p < 0.01).

摘要

本研究的目的是评估肺移植(LT)受者肺炎的流行病学、病因及预后。这是一项针对西班牙LT受者连续队列的前瞻性多中心研究。2003年9月至2005年11月,纳入了236名LT受者中的85例肺炎发作(发病率为每100例LT每年72例发作)。细菌性肺炎(82.7%)比真菌性肺炎(14%)和病毒性肺炎(10.4%)更常见。各病因组中最常见的微生物分别是铜绿假单胞菌(n = 14,24.6%)、巨细胞病毒(CMV,n = 6,10.4%)和曲霉属(n = 5,8.8%)。曲霉属和CMV肺炎的发病率低于先前报道,可能是由于普遍预防措施的推广。病毒引起的肺炎出现时间明显晚于革兰氏阴性杆菌、真菌及病因不明的肺炎(分别为p < 0.01、p = 0.03和p = 0.02)。更昔洛韦的常规使用改变了CMV感染的自然病程,使得肺炎在预防措施暂停后出现得更晚。在多变量分析中,随访第一年无肺炎发作的LT受者的生存概率显著高于至少有一次肺炎发作的受者(p < 0.01)。

相似文献

1
Pneumonia after lung transplantation in the RESITRA Cohort: a multicenter prospective study.RESITRA队列中肺移植后的肺炎:一项多中心前瞻性研究。
Am J Transplant. 2007 Aug;7(8):1989-96. doi: 10.1111/j.1600-6143.2007.01882.x.
2
Pneumonia relevant to lung transplantation and pathogen distribution.与肺移植相关的肺炎及病原体分布。
Chin Med J (Engl). 2013;126(17):3209-14.
3
Pneumonia in allogeneic stem cell transplantation recipients: a multicenter prospective study.异基因造血干细胞移植受者肺炎:一项多中心前瞻性研究。
Clin Transplant. 2011 Nov-Dec;25(6):E629-38. doi: 10.1111/j.1399-0012.2011.01495.x. Epub 2011 Aug 21.
4
Impact of prophylaxis with cytogam alone on the incidence of CMV viremia in CMV-seropositive lung transplant recipients.单独使用赛美维进行预防对巨细胞病毒血清学阳性肺移植受者巨细胞病毒血症发生率的影响。
J Heart Lung Transplant. 2003 Jul;22(7):754-63. doi: 10.1016/s1053-2498(02)00648-4.
5
Bacterial and fungal pneumonias after lung transplantation.肺移植后的细菌性和真菌性肺炎。
Transplant Proc. 2008 Apr;40(3):822-4. doi: 10.1016/j.transproceed.2008.02.049.
6
Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.延长巨细胞病毒预防时间以覆盖肺移植后强化免疫抑制阶段的成本与结果
Chest. 1999 Nov;116(5):1265-72. doi: 10.1378/chest.116.5.1265.
7
Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.肺移植受者呼吸道病毒的流行病学及直接间接影响:一项为期5年的前瞻性研究
Am J Transplant. 2017 May;17(5):1304-1312. doi: 10.1111/ajt.14042. Epub 2016 Oct 14.
8
Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.肺移植受者侵袭性曲霉菌病的临床危险因素:一项国际队列研究结果。
J Heart Lung Transplant. 2018 Oct;37(10):1226-1234. doi: 10.1016/j.healun.2018.06.008. Epub 2018 Jun 21.
9
Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis.尽管进行了延长的抗病毒预防,但巨细胞病毒疾病与肺移植后较高的全因死亡率相关。
Clin Transplant. 2016 Mar;30(3):270-8. doi: 10.1111/ctr.12686. Epub 2016 Mar 1.
10
Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients.肝移植受者中多重耐药革兰氏阴性杆菌引起肺炎的危险因素。
Clin Transplant. 2010 Nov-Dec;24(6):758-65. doi: 10.1111/j.1399-0012.2009.01184.x.

引用本文的文献

1
The association of intraoperative hyperglycemia and postoperative infectious complications after lung transplantation: a single-center retrospective study.肺移植术后术中高血糖与术后感染性并发症的关联:一项单中心回顾性研究
Surg Today. 2025 Jul 4. doi: 10.1007/s00595-025-03083-1.
2
No Emergence of Colistin Resistance in the Respiratory Tract of Lung Transplant Patients Treated With Inhaled Colistin.吸入性黏菌素治疗的肺移植患者呼吸道未出现黏菌素耐药情况。
Transpl Int. 2025 Jan 23;37:13545. doi: 10.3389/ti.2024.13545. eCollection 2024.
3
Epidemiology of Infections in Lung Transplant Recipients Treated With Belatacept.
接受贝拉西普治疗的肺移植受者感染的流行病学
Transpl Infect Dis. 2025 Jan-Feb;27(1):e14403. doi: 10.1111/tid.14403. Epub 2024 Nov 4.
4
Antibiotic Prophylaxis in Patients Undergoing Lung Transplant: Single-Center Cohort Study.肺移植患者的抗生素预防:单中心队列研究。
Transpl Int. 2024 Aug 16;37:13245. doi: 10.3389/ti.2024.13245. eCollection 2024.
5
Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.双侧肺移植后基线期肺移植功能障碍与死亡风险增加相关:一项多中心队列研究的结果
Transplant Direct. 2024 Jun 26;10(7):e1669. doi: 10.1097/TXD.0000000000001669. eCollection 2024 Jul.
6
Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.社区获得性肺炎住院实体器官受者的临床特征、诊断、病因和结局:一项回顾性队列分析。
Chest. 2024 Oct;166(4):697-707. doi: 10.1016/j.chest.2024.05.005. Epub 2024 May 30.
7
The impact and relevance of techniques and fluids on lung injury in machine perfusion of lungs.技术和液体对肺机器灌注中肺损伤的影响和相关性。
Front Immunol. 2024 Mar 6;15:1358153. doi: 10.3389/fimmu.2024.1358153. eCollection 2024.
8
Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review.医院获得性肺炎需更新的十个问题:专家综述
J Clin Med. 2023 Oct 14;12(20):6526. doi: 10.3390/jcm12206526.
9
Long-term management and outcome of lung transplantation in Japan.日本肺移植的长期管理与结果
J Thorac Dis. 2023 Sep 28;15(9):5182-5194. doi: 10.21037/jtd-22-1679. Epub 2023 Jun 27.
10
Association between Hospital-Acquired Pneumonia and In-Hospital Mortality in Solid Organ Transplant Admissions: An Observational Analysis in Spain, 2004-2021.实体器官移植入院患者医院获得性肺炎与院内死亡率之间的关联:2004 - 2021年西班牙的一项观察性分析
J Clin Med. 2023 Aug 25;12(17):5532. doi: 10.3390/jcm12175532.